lenalidomide 20 MG Oral Capsule [Revlimid]

RxCUI: 1429367
RxNorm name: lenalidomide 20 MG Oral Capsule [Revlimid]
Display name: lenalidomide 20 MG Oral Capsule [Revlimid]
Full name: lenalidomide 20 MG Oral Capsule [Revlimid]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Revlimid	LENALIDOMIDE	Celgene Corporation	5fa97bf5-28a2-48f1-8955-f56012d296be	2023-03-24	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1429367

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
5fa97bf5-28a2-48f1-8955-f56012d296be	lenalidomide 20 MG Oral Capsule [Revlimid]	SBD	40	These highlights do not include all the information needed to use REVLIMID ® safely and effectively. See full prescribing information for REVLIMID. REVLIMID (lenalidomide) capsules, for oral use Initial U.S. Approval: 2005	20230324
5fa97bf5-28a2-48f1-8955-f56012d296be	Revlimid 20 MG Oral Capsule	SY	40	These highlights do not include all the information needed to use REVLIMID ® safely and effectively. See full prescribing information for REVLIMID. REVLIMID (lenalidomide) capsules, for oral use Initial U.S. Approval: 2005	20230324
5fa97bf5-28a2-48f1-8955-f56012d296be	Revlimid 20 MG Oral Capsule	PSN	40	These highlights do not include all the information needed to use REVLIMID ® safely and effectively. See full prescribing information for REVLIMID. REVLIMID (lenalidomide) capsules, for oral use Initial U.S. Approval: 2005	20230324